Synthesis and preliminary bioevaluation of 99mTc(CO) 3-17α-triazolylandrost-4-ene-3-one derivative prepared via click chemistry route

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 5, 2011, Pages 539-545

  Dhyani, Manish V ^a   Satpati, Drishty ^a   Korde, Aruna ^a   Banerjee, Sharmila ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

99mTc; androgen receptor; click chemistry; prostate cancer

Indexed keywords

17ALPHA AZIDOANDROST 4 ENE 3 ONE TC 99M; COPPER; RHENIUM COMPLEX; TECHNETIUM 99M; TESTOSTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZIDATION; CANCER CELL CULTURE; CATALYSIS; CHEMICAL REACTION; CLICK CHEMISTRY; CONTROLLED STUDY; DRUG BINDING; DRUG DESIGN; DRUG DISTRIBUTION; DRUG INHIBITION; DRUG SYNTHESIS; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MICROWAVE RADIATION; NONHUMAN; ONE POT SYNTHESIS; PRIORITY JOURNAL; PROSTATE CANCER; UPREGULATION;

ANDROSTERONE; ANIMALS; CELL LINE, TUMOR; CLICK CHEMISTRY; HUMANS; MALE; ORGANOTECHNETIUM COMPOUNDS; PROSTATIC NEOPLASMS; RATS; RATS, WISTAR; RHENIUM; TISSUE DISTRIBUTION; TRIAZOLES;

EID: 80054694552     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.0966     Document Type: Article

References (36)

1. Jemal A, Siegl R, Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin 2009;59:225.
2. Yeole BB, Jussawala DJ. Descriptive epidemiology of the cancers of male genital organs in greater Bombay. Indian J Cancer 1997;34:30.
3. Kattan M, Eastham J, Stapleton A, et al. Preoperative no-mogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766.
4. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843.
5. Kattan MW, Cuzick J, Fisher G, et al. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer 2008;112:69.
6. Srinivas V, Mehta H, Amin A, et al. Carcinomaofthe prostate-state at initial presentation. Int Urol Nephrol 1995;27:419.
7. Katzenellenbogen J. In: Nunn AD (ed.), Radiopharmaceuticals: Chemistry and Pharmacology. New York: Marcel Dekker Inc., 1992;297.
8. Liu A, Dence CS, Welch MJ, et al. Fluorine-18-labeled an-drogens: Radiochemical synthesis and tissue distribution studies on six fluorine-substituted androgens, potential imaging agents for prostatic cancer. J Nucl Med 1992;33:724.
9. 77Br labelled 5a-dihydrotestosterone for scanning the prostate. Eur J Nucl Med 1977;2:155.
10. Tarle M, Padovan R, Spaventi S. The uptake of radio-iodinated 5a-dihydrotestosterone by the prostate of intact and castrated rats. Eur J Nucl Med 1981;6:79.
11. 125I]iodo- 5a-dihydrotestosterone and evaluation of its affinity for the androgen receptor. J Steroid Biochem 1982; 16:621.
12. Skinner RWS, Pozerac RV, Counsell RE, et al. Androgen receptor protein binding properties and tissue distribution of 2-selena-a-nor-5a-androstan-17b-ol in the rat. Steroids 1977;30:15.
13. Liu A, Katzenellenbogen JA, Van Brocklin HF, et al. 20-[18F] fluoromibolerone, a positron-emitting radiotracer for androgen receptors: Synthesis and tissue distribution studies. J Nucl Med 1991;32:81.
14. 99mTc. J Am Chem Soc 1999;121:6076.
15. - in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc 1998;120:7987.
16. +). Helv Chim Acta 2005;88:447.
17. +]G. Bioconjugat Chem 2004;15:128.
18. Levadala MK, Banerjee SR, Maresca KP, et al. Direct reductive alkylation of amino acids: Synthesis of bifunctional chelates for nuclear imaging. Synthesis 2004;11:1759.
19. Kolb HC, Finn MG, Sharpless KB. Click chemistry: Diverse chemical function from a few good reactions. Angew Chem Int Ed 2001;40:2004.
20. Rostotsev VV, Green LG, Fokin VV, et al. A stepwise huis-gen cycloaddition process: Copper (I) catalyzed regio-selective ligation of azides and terminal alkynes. Angew Chem Int Ed 2002;41:2596.
21. Tornoe CW, Christensen C, Meldal M. Peptidotriazoles on solid phase: 1,2,3-Triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem 2002;67:3057.
22. Struthers H, Spingler B, Mindt TL, et al. "Click-to-chelate": Design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest. Chem Eur J 2008;14:6173.
23. Mindt TL, Struthers H, Brans L, et al. Click to chelate: Synthesis and installation of metal chelates into biomole-cules in a single step. J Am Chem Soc 2006;128:15096.
24. 99mTc-labeled testosterone derivative as a potential agent for targeting androgen receptors. Bioorg Med Chem Lett 2006;16;5788.
25. 99mTc, Re) compounds based on the androgen receptor targeting molecule flutamide. Bioconjugate Chem 2009;20:78.
26. 99mTc]-N-[4-nitro-3-trifluoromethyl-phenyl] cyclopenta- dienyltricarbonyl-technetium carboxamide, a nonsteroidal antiandrogen flutamide derivative. Metallomics 2010;2:289.
27. 99mTc) prostate cancer targeted Flutamide agents. Dalton Trans 2010;39:1926.
28. 17a). J Med Chem 1997;40:3297.
29. 17a): Potential agents for the treatment of prostate cancer. J Med Chem 1998;41:902.
30. 17a inhibitors: 17-(2¢-oxazolyl)-and 17-(2¢-thiazolyl)-androstene derivatives. Steroids 2003;68:603.
31. Nnane IP, Long BJ, Ling Y-Z, et al. Anti-tumour effects and pharmacokinetic profile of 17-(5¢-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: An inhibitor of androgen synthesis. Br J Cancer 2000;83:74.
32. 17,20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo. Br J Cancer 1999; 81:622.
33. 6] by alkaline titration. Dalton Trans 1994;19:2815.
34. 76Br]bromo-hydroxyflutamide. Nucl Med Biol 2006;33:705.
35. 76Br]bromo-thiobicalutamide as non-steroidal an-drogens for prostate cancer imaging. J Med Chem 2007; 50:1028.
36. Sjogren J, Li M, Bjorntorp P. Androgen hormone binding to adipose tissue in rats. Biochim Biophys Acta 1995; 1244:117.